ArticleJournal of the American Heart Association2018

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study.

Dennis T Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.